Loading...
Found 22 Acute Myeloid Leukemia trials
A listing of Acute Myeloid Leukemia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Sort by:
- Sort by
- Last updated
This study investigates whether primary palliative care can serve as an alternative to specialty palliative care in improving the quality of life, symptoms, mood, coping, and end-of-life outcomes for patients with acute myeloid leukemia (AML). These patients face a sudden, life-threatening diagnosis requiring immediate hospitalization and treatment, which can cause …
This study investigates the use of CART123 cells in combination with ruxolitinib for patients with relapsed or refractory acute myeloid leukemia (AML). The purpose of this study is to assess the safety and early effectiveness of this combination treatment. Participants will receive a single infusion of CART123 cells after being …
The purpose of this study is understand changes in cognition, physical abilities, and quality of life of individuals receiving venetoclax-based chemotherapy.
This study investigates the effects of an investigational medication in combination with chemotherapy for adults with newly diagnosed FLT3-ITD negative acute myeloid leukemia (AML). This trial will compare the investigational medication to a placebo to see if it improves overall survival in these patients.Participants will receive either the investigational medication …
This study investigates the safety and effectiveness of combining two investigational medications, SNDX-5613 and gilteritinib, for treating relapsed or refractory acute myeloid leukemia (AML) with specific genetic mutations. This study focuses on patients whose leukemia has returned or not responded to treatment and who have mutations in the FLT3 gene, …
This study investigates relapsed/refractory acute myeloid leukemia and myelodysplastic syndromes. It focuses on understanding the effects of an investigational medication called AUTX-703.The study evaluates the safety, tolerability, and how the body processes and responds to AUTX-703. It looks at how effective the investigational medication is in treating the conditions.Who can …
This study investigates the use of an investigational drug called ziftomenib in combination with standard treatments for patients with acute myeloid leukemia (AML). This study focuses on patients with specific genetic changes, such as NPM1 mutations or KMT2A rearrangements, and includes those who are newly diagnosed as well as those …
This study investigates the safety and effectiveness of an investigational medication in patients with advanced blood cancers, including Non-Hodgkin Lymphoma, Multiple Myeloma, Acute Myeloid Leukemia, and high-risk Myelodysplastic Syndrome.Participants in the study will receive the investigational medication either alone or in combination with other treatments. The study will monitor the …
This study investigates a treatment for patients with acute myeloid leukemia (AML) who are not eligible for bone marrow transplantation. The purpose of the study is to evaluate the safety and tolerability of an investigational medication given as maintenance therapy. Patients in this study have AML, which is a type …
This study investigates different treatment approaches for patients with high-risk acute myeloid leukemia (AML), a type of cancer that affects the blood and bone marrow. The study compares the standard treatment of cytarabine and daunorubicin, which are chemotherapy drugs that stop cancer cell growth, with several experimental regimens. These include …
Please choose between Voice or SMS based delivery of verification code
or